FUJIFILM Wako Chemicals USA reposted this
Extracellular Vesicles (EVs) are fast becoming the next therapeutic modality. Learn more about how Fujifilm is leveraging its expertise across four of its life sciences companies - FUJIFILM Diosynth Biotechnologies, FUJIFILM Cellular Dynamics, Inc, FUJIFILM Irvine Scientific and FUJIFILM Wako Chemicals USA FUJIFILM Wako Chemicals Europe GmbH - to provide a full end-to-end range of products and services required for the development and manufacture of EV therapeutics.
